![Biogen agrees to $900 million drug kickback settlement, U.S. Justice Dept says](https://i-invdn-com.investing.com/trkd-images/LYNXMPEI8P11V_L.jpg)
© Reuters. A test tube is seen in front of displayed Biogen logo in this illustration taken, December 1, 2021. REUTERS/Dado Ruvic/Illustration
WASHINGTON (Reuters) – The U.S. Justice Department said on Monday that Biogen Inc (NASDAQ:) had agreed to pay $900 million to resolve allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs, leading to the submission of false Medicare and Medicaid claims.
Be the first to comment